Burden of non-muscle invasive bladder cancer substantial

  • PDF / 167,443 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 29 Downloads / 176 Views

DOWNLOAD

REPORT

1173-5503/20/0868-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 12 Dec 2020 No. 868

1

Data Loading...

Recommend Documents
Management of Non-Muscle Invasive Bladder Cancer

162 62 5MB

Neonatal bloodstream infection substantial burden in Ghana

215 97 163KB

Bladder Cancer: Muscle-Invasive Disease, Neoadjuvant Chemotherapy, and Radical Cystectomy

165 91 7MB

Deep Learning Based Pathologic Images Recognition Upon Invasive Bladder Cancer

167 80 93MB

Informal care for patients with AF substantial burden

153 2 166KB

Bladder Cancer

177 86 9MB

Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer

164 12 3MB

Cancer, Bladder

189 80 35MB

Chronic graft-versus-host disease substantial economic burden in Sweden

147 57 166KB

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systemat

150 70 1MB

Treating Urothelial Bladder Cancer

192 21 4MB

Worldwide Burden of Gynecological Cancer

138 82 742KB